Careers

Diversity

With 18 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Amy Ralph Mudge Participates in Pre-Conference Social Media Advertising Workshop

Efforts to Expand Mini-WARN Acts’ Requirements Underscore the Importance of Knowing State-Level, Post-Sale Obligations Relating to a Plant Closing or a Mass Layoff (Employee Relations Law Journal)

IP Intelligence Report

Irreparable Harm Reimagined: The Government’s Patent Intervention in East Texas

Employment Law Spotlight

New York Senate Passes Half-Million-Dollar Noncompete Wage Limit

Tim assists clients in understanding, negotiating&nbsp;and closing complex technology transactions. He also helps clients on both buy and sell-side M&amp;A transactions, with a focus on technology dependent targets. In addition, Tim shepherds companies and investors through financings, including convertible notes, SAFEs and preferred equity rounds, and corporate governance matters. Having worked with private equity and venture capital funds, and having advised many of their portfolio companies, Tim is able to succinctly counsel companies as they navigate the unique dynamics of their relationships with investors and owners.

core/freeform

J.D., The University of Chicago Law School, 2006, 

B.S., Mechanical Engineering, Rose-Hulman Institute of Technology, 2003, 

<ul>
<li>LMG Expert Guides, Rising Star for Technology, Media &amp; Telecom / IT (2015)</li>
<li>Chambers USA
<ul>
<li>Corporate/M&amp;A in Ohio
<ul>
<li>Band 3 (2025), Band 4 (2024), Up and Coming (2020 to 2023)</li>
</ul>
</li>
<li>Technology and Outsourcing in Illinois
<ul>
<li>Associate to Watch (2013 to 2014)</li>
</ul>
</li>
</ul>
</li>
<li>The Legal 500 United States (2013)
<ul>
<li>Recommended for Media, Technology and Telecoms</li>
</ul>
</li>
</ul>

Cincinnati

BakerHostetler Team Represents MNP Corporation, Fitzgerald Finishing LLC and Cadon Plating & Coatings, LLC in Acquisition by Italy-based Gruppo Fontana

Chambers USA Guide 2025 Recognizes 171 BakerHostetler Attorneys and 73 Practice Areas

Tim Swan Participates in Panel at Life Sciences AI Summit

Life Sciences Industry Team Hosts Reception During BIO International Convention

Chambers USA Guide 2024 Recognizes 155 BakerHostetler Attorneys and ­66 Practice Areas

BakerHostetler deal team helps facilitate $1.385 billion acquisition

Chambers USA Guide 2023 Honors 147 BakerHostetler Attorneys and Recognizes 64 Practice Areas

Chambers USA Guide 2022 Honors 145 BakerHostetler Attorneys and Recognizes 62 Practice Areas

Webinar: Understanding New Technologies and How to Utilize Them While Staying Compliant

Intellectual Property

Corporate Governance

Mergers and Acquisitions

Digital Assets and Data Management

Business

Emerging Companies and Venture Capital

Software

Artificial Intelligence (AI)

Privacy Governance and Technology Transactions

Emerging Technology

Industries

Life Sciences

Life Sciences
<ul>
<li>Represented a medical device development company in a “build-to-buy” option / merger transaction with a leading strategic in the field, with an enterprise value in excess of $500 million based on the acquisition price.</li>
<li>Counseled GE Healthcare in connection with the formation of Intel GE Care Innovations, a joint venture with Intel Corporation, to develop and market home-based health technologies; and its formation of Caradigm, a joint venture with Microsoft Corporation to develop and market a unified data aggregation and analysis platform for healthcare providers.</li>
<li>Acts as outside general counsel to several medical device contract manufacturing enterprises.</li>
<li>Represented RoundTable Healthcare Partners regarding IP aspects in various pharmaceutical and medical device acquisitions, including its sale of CorePharma LLC and other companies to Impax Laboratories Inc. for $700 million and Aspen Surgical Products holding, Inc. to Hill-Rom Holdings, Inc. for $400 million.</li>
<li>Counseled GE Healthcare regarding IP aspects in a number of acquisitions, including Living Independently Group Inc., MicroCal LLC, Orbotech Medical Solutions Ltd., U-Systems, Inc., Steady State Imaging and part of Unisyn Medical Technologies.</li>
<li>Represented public biopharmaceutical company in negotiation of several multiyear services and supply agreements with multiple contract research organizations and contract manufacturing organizations, with over $50 million in commitments.</li>
<li>Advised Catamaran in its acquisition by OptumRx (UnitedHealth Group’s free-standing pharmacy care services business) for $12.8 billion, and in various licensing agreements.</li>
<li>Represented Takeda Pharmaceuticals Company regarding the IP aspects of its $800 million acquisition of URL Pharma, Inc.</li>
<li>Advised GlaxoSmithKline plc regarding the IP aspects of its sale of a hepatitis C treatment candidate to Janssen Pharmaceuticals.</li>
<li>Counseled Dicerna in its licensing of Tekmira’s proprietary lipid nanoparticle technology for delivery of one of its RNAi candidates, with potential for $24.5 million in milestones in addition to ongoing royalties.</li>
<li>Counseled preclinical biopharmaceutical company on licensing of therapeutic candidates from several universities.</li>
<li>Represent biopharma development company in the sale of its Indeno therapeutics pipeline.</li>
</ul>
Startup Venture Capital
<ul>
<li>Company side &#8211; medical device manufacturer in $120 million Series A round, with multiple financing milestones.</li>
<li>Company side &#8211; energy sciences company in numerous convertible note and priced equity rounds, with over $20 million raised.</li>
<li>Company side &#8211; preclinical biopharmaceutical company in numerous financing rounds, with over $8 million raised.</li>
<li>Company side &#8211; advertising technology company in numerous convertible note and priced equity rounds, with over $8 million raised.</li>
<li>Company side &#8211; healthcare IT company in $4.5 million recapitalization.</li>
<li>Investor side &#8211; lead strategic investor in $58 million Series B investment in an autonomous driving company.</li>
<li>Investor side &#8211; strategic investor in a $5 million Series Seed round investment in a beverage company.</li>
<li>Investor side &#8211; lead investor in $1.25 million SAFE round investment in a veterinary device manufacturer.</li>
<li>Investor side &#8211; lead investor in $5 million Series C round investment in construction technology company.</li>
<li>Investor side &#8211; strategic investor in $40 million D round investment in auction technology company.</li>
</ul>
Technology Transactions and Other Matters
<ul>
<li>Advised Iridium Communications on a wide range of intellectual property and technology license and development agreements, including the intellectual property aspects of agreements underpinning its current satellite constellation.</li>
<li>Counseled The Hartford Financial Services Group on technology and transition matters in its divestiture of four businesses at the same time with a total price of over $1 billion, including retirement, individual life insurance, variable annuity and broker dealer businesses.</li>
<li>Represented Global Healthcare Exchange in various license and services agreements, including its agreements with several group purchasing organizations.</li>
<li>Represented Global Healthcare Exchange in the acquisitions of a payments processing target and a remote case support technology target.</li>
<li>Advised international accounting firm on procurement of various strategic software and SaaS applications, with aggregate subscription fees in excess of $100 million.</li>
<li>Represented Sara Lee Corp., in trademark licenses and other IP aspects of the nearly $1 billion sale of its North American fresh bakery business.</li>
<li>Represented Monsanto Company in its $300 million long-term strategic alliance with Novozymes to research and commercialize sustainable microbial products in the agriculture industry.</li>
<li>Counseled Beam Inc. regarding IP aspects of its $16 billion acquisition by Suntory Holdings Limited.</li>
</ul>

Timothy M. Swan

Timothy M. Swan

Experience

Recognitions and Memberships

Insights and News

Credentials

Community and Pro Bono

Areas of Focus

Industries

Services

Featured Insights